Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Safety and Immune Response to a Prime-Boost Vaccination Schedule in HIV-infected Patients

This study has been completed.
Sponsor:
Information provided by:
National Institutes of Health Clinical Center (CC)
ClinicalTrials.gov Identifier:
NCT00270465
First received: December 24, 2005
Last updated: September 3, 2009
Last verified: June 2009